Ligand validation:2I3I

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2I3I_BTB_B_301	2%	82%	0.465	0.762	0.47	0.33	-	-	0	0	100%	1
2I3H_BTB_B_401	7%	90%	0.319	0.77	0.25	0.37	-	-	0	0	100%	1
1TW6_BTB_B_331	6%	93%	0.245	0.673	0.25	0.23	-	-	0	0	100%	1
5O5D_BTB_A_604	100%	59%	0.022	0.994	0.89	0.68	1	-	2	0	100%	1
9CWK_BTB_B_505	100%	80%	0.025	0.996	0.31	0.53	-	-	2	0	100%	1
9CW6_BTB_C_504	100%	51%	0.028	0.996	0.41	1.45	-	1	4	0	100%	1
9Q4X_BTB_A_504	100%	62%	0.027	0.995	0.56	0.88	-	-	6	0	100%	1
9Q58_BTB_A_504	100%	66%	0.029	0.995	0.43	0.88	-	-	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.